E71.51 - Disorders of peroxisome biogenesis
- Applicable to Disorders of peroxisome biogenesis
- The 2025 edition of ICD10-CM E71.51 became effective on October 1, 2024.
- This is the American ICD10-CM version of E71.51 - other international versions of ICD10 E71.51 may differ.
- E71.51 is a Non-Billable / Non-Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- E71.51 Code should not be used for billing or reimbursement purposes as there are multiple ICD-10 CM codes below it that contain a greater level of detail.
- E71.51 - Disorders of peroxisome biogenesis
- E71.51 - Disorders of peroxisome biogenesis
- E71.510 - Zellweger syndrome
- E71.511 - Neonatal adrenoleukodystrophy
- E71.518 - Other disorders of peroxisome biogenesis
Inclusion Term
- Group 1 peroxisomal disorders
Type 1 Excludes
- Refsum's disease (G60.1)
The following codes above E71.51 contain annotation back-references that may be applicable to E71.51:
Chapter: E00-E89 Endocrine, nutritional and metabolic diseases
Section: E70-E88 Metabolic disorders
Category: E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
Non-Billable/Non-Specific Code
Browse other similar CM codes
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd-10code.com